Genetic Construction, Expression, and Characterization of Diphtheria Toxin-Based Growth Factor Fusion Proteins
Part of the
Methods in Molecular Biology™
book series (MIMB, volume 145)
The fusion protein toxins that have been described are generally composed of the catalytic and transmembrane domains of a bacterial toxin (e.g., diphtheria toxin [DT] or Pseudomonas exotoxin A) to which a polypeptide hormone, growth factor, or single-chain antibody (scFv) is genetically fused (1, 2, 3). In these constructs, the native receptor binding domain of the toxin is genetically replaced with the targeting ligand. Our laboratory has focused almost exclusively on the construction, expression, and characterization of DT-based fusion toxins (1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12). We have used these novel cytotoxic reagents as probes to study structure-function relationships of the DT catalytic and transmembrane domains, as well as to study the receptor binding components of the fusion proteins (13, 14, 15, 16, 17, 18, 19). We are currently using these novel reagents to study the underlying mechanisms involved with delivery of the fusion protein toxin’s catalytic domain across the membrane and into the cytosol of target eucaryotic cells. The catalytic domain of diphtheria toxin catalyzes the NAD+-dependent ADP-ribosylation of the diphthamide residue in elongation factor 2, resulting in inhibition of protein synthesis (20,21). As the delivery of a single molecule of the catalytic domain to the eucaryotic cell cytosol has been shown to result in the death of that cell, the fusion protein toxins represent a family of highly potent, receptor-specific, cytotoxic probes (22).
KeywordsDiphtheria Toxin Bacterial Pellet Receptor Binding Domain Refold Buffer Fusion Toxin
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Brinkman U., Reiter Y., Jung S-H., Lee B., and Pastan I. (1993) A recombinant imM
unotoxin containing a disulfide-stabilized Fv fragment (dsFv). Proc. Natl. Acad. Sci. USA
, 7538–7542.CrossRefGoogle Scholar
Murphy J. R. and vanderSpek J. C. (1995) Targeting diphtheria toxin to growth factor receptors. Semin. Cancer Biol.
, 259–267.PubMedCrossRefGoogle Scholar
Kreitman R. J. and Pastan I. (1995) Targeting Pseudomonas exotoxin to hematologic malignancies. Semin. Cancer Biol.
, 297–306.PubMedCrossRefGoogle Scholar
Murphy J. R., Bishai W., Borowski M., Miyanohara A., Boyd J., and Nagle S. (1986) Genetic construction, expression and melanoma-selective cytotoxicity of a diphtheria toxin-α-melanocyte stimulating hormone fusion protein. Proc. Natl. Acad. Sci. USA
, 8258–8262.PubMedCrossRefGoogle Scholar
Williams D., Parker K., Bishai W., Borowski M., Genbauffe F., Strom T. B., and Murphy J. R. (1987) Diphtheria-toxin receptor binding domain substitution with interleukin-2: genetic construction and properties of a diphtheria toxin-related interleukin-2 fusion protein. Protein Engng.
, 493–498.CrossRefGoogle Scholar
Lakkis F., Steele A., Pacheco-Silva A., Kelley V. E., Strom T.B., and Murphy. J. R. (199l) Interleukin-4 receptor targeted cytotoxicity: genetic construction and properties of diphtheria toxin-related interleukin l fusion toxins. Eur. J. Im
, 2253–2258.Google Scholar
Aullo P., Alcani J., Popoff M. R., Klatzman D. R. Murphy J. R., and Boquet P. (1992) In vitro
effects of a recombinant diphtheria-human CD4 fusion toxin on acute and chronically HIV-1 infected cells. EMBO J.
, 921–931.Google Scholar
Jean L.-F. and Murphy J. R. (1992) Diphtheria toxin receptor binding domain substitution with interleukin-6: genetic construction and interleukin-6 receptor specific action of a diphtheria toxin-related interleukin-6 fusion protein. Protein Engng.
, 989–994.CrossRefGoogle Scholar
vander Spek J. C, Sutherland J., Sampson E., and Murphy J. R. (1995) Genetic construction and characterization of the diphtheria toxin-related interleukin 15 fusion protein DAB389
sIL-15. Protein Engng.
, 1317–1321.CrossRefGoogle Scholar
Fisher C. E., Sutherland J. A., Krause J. E., Murphy J. R., Leeman S. E., and vanderSpek J. C. (1996) Genetic construction and properties of a diphtheria toxin-related substance P fusion protein: in vitro
destruction of cells bearing substance P receptors. Proc. Natl. Acad. Sci. USA
, 7341–7345.PubMedCrossRefGoogle Scholar
vanderSpek J. C, Sutherland J. A., Zeng H., Battey J. F., Jensen R. T., and Murphy J. R. (1997) Inhibition of protein synthesis in small cell lung cancer cells induced by the diptheria toxin-related fusion protein DAB389
GRP. Cancer Res.
, 290–294.PubMedGoogle Scholar
Sweeney E. B., Foss F. M., Murphy J. R., and vanderSpek J. C. (1998) Interleukin 7 (IL-7) receptor-specific cell killing by DAB389
IL-7: a novel agent for the elimination of IL-7 receptor positive cells. Bioconj. Chem.
, 201–207.CrossRefGoogle Scholar
Williams D., Snider C. E., Strom T. B., and Murphy J. R. (1990) Structure function analysis of IL-2 toxin (DAB486
IL-2): fragment B sequences required for the delivery of fragment A to the cytosol of target cells. J. Biol. Chem.
. 11,885–11,889.PubMedGoogle Scholar
Williams D. P., Wen Z., Watson R. S., Boyd J., Strom T. B., and Murphy J. R. (1990) Cellular processing of the interleukin-2 fusion toxin DAB486
-IL-2 and efficient delivery of diphtheria fragment A to the cytosol of target cells requires Arg194
. J. Biol. Chem.
, 20673–20677.PubMedGoogle Scholar
vanderSpek J. C, Mindell J. A., Finkelstein A., and Murphy J. R. (1993) Structure/function analysis of the transmembrane domain DAB389
-IL-2, an interleukin-2 receptor-targeted fusion toxin. J. Biol. Chem.
, 12077–12082.PubMedGoogle Scholar
vanderSpek J. C, Howland K., Friedman T., and Murphy J. R. (1994) Maintenance of the hydrophobic face of the diphtheria toxin amphipathic transmembrane helix 1 is essential for the efficient delivery of the catalytic domain to the cytosol of target cells. Protein Engng.
, 985–989.CrossRefGoogle Scholar
vanderSpek J. C, Cassidy D., Genbauffe F., Huynh P. D., and Murphy J. R.(1994) An intact transmembrane helix 9 is essential for the efficient delivery of the diphtheria toxin catalytic domain to the cytosol of target cells. J. Biol. Chem.
, 21,455–21,459.PubMedGoogle Scholar
vanderSpek J. C, Sutherland J. A., Ratnarathorn M., Howland K., Ciardelli T. L., and Murphy J. R. (1996) DAB389
IL-2 receptor binding domain mutations: cytotoxic probes for studies of ligand/receptor interactions. J. Biol. Chem.
. 2145–12149.Google Scholar
Hu H.-Y., Huynh P. D., Murphy J.R., and vanderSpek J. C. (1998) The effects of helix breaking mutations in the diphtheria toxin transmembrane domain helix layers of the fusion toxin DAB389
IL-2. Protein Engng.
, 101–107.CrossRefGoogle Scholar
Robinson E. A., Henriksen O., and Maxwell E. S. (1974) Elongation factor 2; amino acid sequence at the site of adenosine diphosphate ribosylation. J. Biol.Chem.
, 5088–5093.PubMedGoogle Scholar
Van Ness B. G., Howard J. B., and Bodley J. W. (1980) ADP-ribosylation of elongation factor 2 by diphtheria toxin: isolation and properties of the novel ribosyl-amino acid and its hydrolysis products. J. Biol. Chem.
, 10,717–10,720.PubMedGoogle Scholar
Yamaizumi K., Mekada E., Uchida T., and Okada Y. (1978) One molecule of diphtheria toxin fragment A introduced into a cell can kill the cell. Cell
, 245–250.PubMedCrossRefGoogle Scholar
Studier F. W. and Moffatt B. A. (1986) Use of bacteriophage T7 RNA poly-merase to direct selective high-level expression of cloned genes. J. Mol. Biol.
, 113–130.PubMedCrossRefGoogle Scholar
Rosenberg A. H., Lade B. N., Chui D., Lin S., Dunn J. J., and Studier F. W. (1987) Vectors for selective expression of cloned DNAs by T7 RNA polymerase. Gene
, 125–135.PubMedCrossRefGoogle Scholar
Studier F. W., Rosenberg A. H., Dunn J. J., and Dubendorff J. W. (1990) Useof T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol.
, 60–89.PubMedCrossRefGoogle Scholar
Ausubel F. M., Brent R., Kingston R. E., Moore D. D., Seidman J. G., Smith J. A., and Struhl K. (1988) Current Protocob in Molecular Biology
, John Wiley & Sons, New York.Google Scholar
Sanger F., Nicklen S., and Coulsen A. R. (1977) DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA
, 5463–5467.PubMedCrossRefGoogle Scholar
Kraft R., Tardiff J., Krauter K. S., and Leinwand L. A. (1988) Using mini-prep plasmid DNA for sequencing double stranded template with sequenase. BioTechniques
, 544–547.PubMedGoogle Scholar